Biospecifics Technologies (BSTC) Tops Q1 EPS by 3c
Get Alerts BSTC Hot Sheet
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q1 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6.25 million.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- DLocal Limited (DLO) Misses Q4 EPS by 5c, offers outlook
- Alpine Immune Sciences (ALPN) Reports FY Loss of $0.64
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!